Future investigative directions for novel therapeutic targets in head and neck cancer. Read more about Future investigative directions for novel therapeutic targets in head and neck cancer.
Management of breast cancer diagnosed during pregnancy: global perspectives. Read more about Management of breast cancer diagnosed during pregnancy: global perspectives.
The evolution of cyclin dependent kinase inhibitors in the treatment of cancer. Read more about The evolution of cyclin dependent kinase inhibitors in the treatment of cancer.
Achieving efficacious immunotherapy for patients with glioblastoma. Read more about Achieving efficacious immunotherapy for patients with glioblastoma.
Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC. Read more about Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC.
Emerging data on improving response to hormone therapy: the role of novel targeted agents. Read more about Emerging data on improving response to hormone therapy: the role of novel targeted agents.
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment. Read more about Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment.
Emerging antiangiogenic therapies for non-small-cell lung cancer. Read more about Emerging antiangiogenic therapies for non-small-cell lung cancer.
Therapeutic potential of PARP inhibitors for metastatic breast cancer. Read more about Therapeutic potential of PARP inhibitors for metastatic breast cancer.
Symptom management in gynecologic malignancies. Read more about Symptom management in gynecologic malignancies.
